Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs

Journal of Medicinal Chemistry

Volumn 51, Issue 15, 2008, Pages 4581-4588

  More, Swati S ^a,b   Vince, Robert ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DOPAMINE; GLUTATHIONE; PRODRUG;

ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG HALF LIFE; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; NONHUMAN; PARKINSON DISEASE; RAT;

ALDEHYDES; AMIDES; ANIMALS; BIOLOGICAL TRANSPORT; BIOMIMETIC MATERIALS; BLOOD-BRAIN BARRIER; CELL LINE; CELL MEMBRANE; DRUG DESIGN; GLUTATHIONE; HUMANS; MOLECULAR STRUCTURE; PARKINSON DISEASE; PEPTIDES; PRODRUGS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 49449113969     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800239v     Document Type: Article

References (20)

1. Pardridge, W. M. Blood-brain Barrier Drug Targeting: The Future of Brain Drug Development. Mol. Interventions 2003, 3, 90-105.
2. Han, H. K.; Amidon, G. L. Targeted Prodrug Design to Optimize Drug Delivery. AAPS PharmSci. 2000, 2, 1-11.
3. Bonina, F.; Lanza, M.; Montenegro, L.; Salerno, L.; Smeriglio, P.; Trombetta, D.; Saija, A. Transport of Alpha-Tocopherol and Its Derivatives Through Erythrocyte Membranes. Pharm. Res. 1996, 13, 1343-1347.
4. Fujita, T.; Kishida, T.; Wada, M.; Okada, N.; Yamamoto, A.; Leibach, F. H.; Ganapathy, V. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2. Brain Res. 2004, 997, 52-61.
5. Daniel, H.; Rubio-Aliaga, I. An Update on Renal Peptide Transporters. Am. J. Physiol. Renal Physiol. 2003, 284, F885-F892.
6. Lotharius, J.; Brundlin, P. Pathogenesis of Parkinson's Disease: Dopamine, Vesicles and α-Synuclein. Nat. Rev. Neurosci. 2002, 3, 932-942.
7. (a) Kannan, R.; Kuhlenkamp, J. F.; Jeandidier, E.; Trinh, H.; Oakhtens, M.; Kaplowitz, N. Evidence for Carrier-mediated Transport of Glutathione Across the Blood-Brain Barrier in the Rat. J. Clin. Invest. 1990, 85, 2009-2013.
8. (b) Kannan, R.; Yi, J. R.; Tang, D.; Li, Y.; Zlokovic, B. V.; Kaplowitz, N. Evidence for the Existence of a Sodium-Dependent Glutathione (GSH) Transporter. J. Biol. Chem. 1996, 271, 9754-9758.
9. Wang, H.; Lee, J.; Tsai, M.; Lu, H.; Hsu, W. Synthesis and Pharmacological Activities of a Novel Tripeptide Mimetic Dopamine Prodrug. Bioorg. Med. Chem. Lett. 1995, 5, 2195-2198.
10. Bonina, F.; Puglia, C.; Rimoli, M. G.; Melisi, D.; Boatto, G.; Nieddu, M.; Calignano, A.; La Rana, G.; De Caprariis, P. Glycosyl Derivatives of Dopamine and L-dopa as Anti-Parkinson Prodrugs: Synthesis, Pharmacological Activity and In Vitro Stability Studies. J. Drug. Targeting 2003, 11, 25-36.
11. Bai, J. P. F. pGlu-L-Dopa-Pro: A Tripeptide Prodrug Targeting the Intestinal Peptide Transporter for Absorption and Tissue Enzymes for Conversion. Pharm. Res. 1995, 12, 1101-1104.
12. Vince, R.; Brownell, J.; Akella, L. B. Synthesis and Activity of γ-(L-γ-azaglutamyl)-S-(p-bromobenzyl) -L-cysteinylglycine: A Metabolically Stable Inhibitor of Glyoxalase I. Bioorg. Med. Chem. Lett. 1999, 9, 853-856.
13. More, S. S.; Vince, R. A Metabolically Stable Tight-binding Transition-State Inhibitor of Glyoxalase-I. Bioorg. Med. Chem. Lett. 2006, 16, 6039-6042.
14. Bickel, U.; Kang, Y. S.; Pardridge, W. M. In Vivo Cleavability of a Disulfide-Based Chimeric Opioid Peptide in Rat Brain. Bioconjugate Chem. 1995, 6, 211-218.
15. Hughes, P.; Clardy, J. Total synthesis of 3(S)-carboxy-4(S) -hydroxy-2,3,4,5-tetrahydropyridazine, an unusual amino acid constituent of luzopeptin A. J. Org. Chem. 1989, 54, 3260-3264.
16. Lipták, A.; Sajtos, F.; Jánossy, L.; Gehle, D.; Szilágyi, L. A General Method for the Synthesis of Sugar 2-C-Sulfonic Acids by 1 → 2 Arylthio Group Migration in Acid-Sensitive Thioglycosides. Direct Transformation of Thiotrityl Ethers into C-Sulfonic Acids. Org. Lett. 2003, 5, 3671-3674.
17. Rietman, B. H.; Peters, R. F. R.; Tesser, G. I. A Facile Method for the Preparation of S-(Alkylsulfenyl)cysteines. Synth. Commun. 1994, 24, 1323-1332.
18. Gumbleton, M.; Audus, K. L. Progress and Limitations in the Use of In Vitro Cultures to Serve as a Permeability Screen for the Blood-Brain Barrier. J. Pharm. Sci. 2001, 90, 1681-1698.
19. Udenfriend, S.; Stein, S.; Böhlen, P.; Dairman, W.; Leimgruber, W.; Weigele, M. Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range. Science 1972, 178, 871-872.
20. Benson, J. R.; Hare, P. E. o-Phthalaldehyde: Fluorogenic Detection of Primary Amines in the Picomole Range. Comparison with Fluorescamine and Ninhydrin. Proc. Natl. Acad. Sci. U.S.A. 1975, 72, 619-622.